
About Celera Pharma
Celera Pharma is a Healthcare company based in India. Pharmaceutical formulations in healthcare sectors including Nephrology and Cardiology. Its Indian entity Celera Pharma Private Limited reported revenue of βΉ22.48 Cr. Celera Pharma offers products and services including Nephrology Products and Cardiology Products. Its focus areas include Pharmaceuticals, Nephrology, Formulations and Cardiology.
Company details
Celera Pharma is recognized as a leading biotechnology company that markets formulations across India, focusing on areas such as Nephrology, Cardiology, General Medicine, Urology, and Neurology. Quality medicines are delivered to enhance patient healthcare, with an emphasis on improving life quality through innovative offerings. The company is guided by principles of relentless growth via change management, empowerment of diverse abilities, and commitment to social responsibility for the common good. Continuous pursuit of excellence is maintained in its operations.
- Headquarters India
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Website celerapharma.in
- Legal Name Celera Pharma Pvt. Ltd
- Date of Incorporation 03 Feb, 2011
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹22.48 Cr
FY 2025 · +23% YoY
- Net Profit₹97.8 Lakh
FY 2025 · 4% margin
- EBITDA₹1.38 Cr
FY 2025 · 6% margin
Associated legal entities of Celera Pharma
Celera Pharma operates through Celera Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Celera Pharma Private Limited CIN U24232TG2011PTC072493 | Active | 03 Feb 2011 | Hyderabad, Telangana | ₹22.5 Cr | 2 | View details |
Products & Services of Celera Pharma
Celera Pharma offers a comprehensive portfolio of products and services, including Nephrology Products and Cardiology Products.
Nephrology formulations are marketed for essential healthcare needs.
Cardiology medicines are provided as part of the product range for patient care.
Board of directors of Celera Pharma Private Limited (Celera Pharma)
Celera Pharma Private Limited is the primary company behind Celera Pharma. The board of Celera Pharma Private Limited currently have 2 directors; the longest-serving is Sabitha Kalluri, appointed in 2014. 4 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sabitha Kalluri DIN 06975630 | Director | 20 Sep 2014 | 12 yrs 2 mo | Celera Pharma Private Limited |
| Ravi Mahanthi DIN 09694871 | Director | 04 Aug 2022 | 4 yrs 3 mo | Celera Pharma Private Limited |
Financials of Celera Pharma
Figures of Celera Pharma Private Limited, the primary company behind Celera Pharma, for FY 2025. Revenue was ₹22.48 Cr (+23% year on year). Net profit was ₹97.8 Lakh (4% margin). EBITDA was ₹1.38 Cr (6% margin). Revenue has grown at a compounded annual rate of 0% over three years and +15% over five years.
- ₹22.48 CrRevenue · FY 2025 · +23% YoY
- ₹97.8 LakhNet profit · 4% margin
- ₹1.38 CrEBITDA · 6% margin
- ₹1 LakhPaid-up capital
- 0%Revenue CAGR, 3 years
- +15%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Celera Pharma Private Limited are on its company page.
Detailed financial statements for Celera Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Celera Pharma
Celera Pharma is headquartered in India.
The primary company behind Celera Pharma, Celera Pharma Private Limited, reported revenue of βΉ22.48 Cr for FY 2025, up 23% year on year.
Celera Pharma is recognized as a leading biotechnology company that markets formulations across India, focusing on areas such as Nephrology, Cardiology, General Medicine, Urology, and Neurology. Quality medicines are delivered to enhance patient healthcare, with an emphasis on improving life quality through innovative offerings. The company is guided by principles of relentless growth via change management, empowerment of diverse abilities, and commitment to social responsibility for the common good. Continuous pursuit of excellence is maintained in its operations.
Celera Pharma offers Nephrology Products and Cardiology Products.
Celera Pharma operates through Celera Pharma Private Limited.
The legal entities of Celera Pharma currently have 2 directors, including Sabitha Kalluri, Ravi Mahanthi.